+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Global Continuous Renal Replacement Therapy Market by Product, Modality, Age Group, Indication, End User - Forecast 2023-2030 - Product Thumbnail Image

Global Continuous Renal Replacement Therapy Market by Product, Modality, Age Group, Indication, End User - Forecast 2023-2030

  • Report
  • March 2024
  • 187 Pages
  • Global
From
Global Bone Morphogenetic Protein Market by Type (rhBMP-2, rhBMP-7), Application (Oral Maxillofacial, Reconstruction, Spinal fusion) - Forecast 2024-2030 - Product Thumbnail Image

Global Bone Morphogenetic Protein Market by Type (rhBMP-2, rhBMP-7), Application (Oral Maxillofacial, Reconstruction, Spinal fusion) - Forecast 2024-2030

  • Report
  • March 2024
  • 189 Pages
  • Global
From
Global Kidney Stone Retrieval Devices Market by Product Type (Lithotripters, Stone Removal Baskets, Ureteral Stents), Treatment (Extracorporeal Shock Wave Lithotripsy, Intracorporeal Ureteroscopy, Percutaneous Nephrolithotripsy), End-Use - Forecast 2024-2030 - Product Thumbnail Image

Global Kidney Stone Retrieval Devices Market by Product Type (Lithotripters, Stone Removal Baskets, Ureteral Stents), Treatment (Extracorporeal Shock Wave Lithotripsy, Intracorporeal Ureteroscopy, Percutaneous Nephrolithotripsy), End-Use - Forecast 2024-2030

  • Report
  • March 2024
  • 194 Pages
  • Global
From
Focal Segmental Glomerulosclerosis: Global Strategic Business Report - Product Thumbnail Image

Focal Segmental Glomerulosclerosis: Global Strategic Business Report

  • Report
  • April 2024
  • 194 Pages
  • Global
From
Liver Diseases Treatment: Global Strategic Business Report - Product Thumbnail Image

Liver Diseases Treatment: Global Strategic Business Report

  • Report
  • April 2024
  • 194 Pages
  • Global
From
Non-alcoholic Steatohepatitis (NASH): Global Strategic Business Report - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH): Global Strategic Business Report

  • Report
  • April 2024
  • 179 Pages
  • Global
From
End-Stage Renal Disease - Global Strategic Business Report - Product Thumbnail Image

End-Stage Renal Disease - Global Strategic Business Report

  • Report
  • April 2024
  • 89 Pages
  • Global
From
Hepatitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Hepatitis Therapeutics - Global Strategic Business Report

  • Report
  • April 2024
  • 94 Pages
  • Global
From
Hepatitis C Treatment: Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Treatment: Global Strategic Business Report

  • Report
  • April 2024
  • 208 Pages
  • Global
From
Chronic Kidney Disease (CKD) Drugs - Global Strategic Business Report - Product Thumbnail Image

Chronic Kidney Disease (CKD) Drugs - Global Strategic Business Report

  • Report
  • April 2024
  • 179 Pages
  • Global
From
Erythropoietin Drugs - Global Strategic Business Report - Product Thumbnail Image

Erythropoietin Drugs - Global Strategic Business Report

  • Report
  • April 2024
  • 179 Pages
  • Global
From
Diabetic Nephropathy Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Nephropathy Treatment - Global Strategic Business Report

  • Report
  • April 2024
  • 196 Pages
  • Global
From
Potassium Citrate - Global Strategic Business Report - Product Thumbnail Image

Potassium Citrate - Global Strategic Business Report

  • Report
  • April 2024
  • 182 Pages
  • Global
From
Global Hepatitis Therapeutics Market 2030 by Hepatitis Type, Drug Class, Drug Type, End-user and Distribution Channel and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints - Product Thumbnail Image

Global Hepatitis Therapeutics Market 2030 by Hepatitis Type, Drug Class, Drug Type, End-user and Distribution Channel and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints

  • Report
  • August 2023
  • 180 Pages
  • Global
From
Global Liver Disease Diagnostics Market Size, Share & Trends Analysis Report by Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy, Others), End-use (Hospitals, Laboratories, Others), Region, and Segment Forecasts, 2023-2030 - Product Thumbnail Image

Global Liver Disease Diagnostics Market Size, Share & Trends Analysis Report by Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy, Others), End-use (Hospitals, Laboratories, Others), Region, and Segment Forecasts, 2023-2030

  • Report
  • November 2023
  • 80 Pages
  • Global
From
Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Product (System, Consumables), By Modality, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Product (System, Consumables), By Modality, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 110 Pages
  • Global
From
Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User - Global Forecast to 2030 - Product Thumbnail Image

Point-of-Care Diagnostics Market by Platform (LFA, Molecular), Application (TB, Pneumonia, Salmonellosis, Hepatitis, HIV, COVID-19, Pregnancy, Blood Glucose Monitoring, Hematology, Tumor), Sample Type (Blood, Urine), and End User - Global Forecast to 2030

  • Report
  • May 2023
  • 395 Pages
  • Global
From
Global Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel, End User, and Region 2024-2032 - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis Market by Drug Type, Disease Cause, Sales Channel, End User, and Region 2024-2032

  • Report
  • April 2024
  • 137 Pages
  • Global
From
Global Erythropoietin Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Thumbnail Image

Global Erythropoietin Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • November 2023
  • 144 Pages
  • Global
From
Potassium Citrate Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Thumbnail Image

Potassium Citrate Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • June 2023
  • 149 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more